These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 25521389

  • 1. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S.
    Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
    [Abstract] [Full Text] [Related]

  • 2. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [Abstract] [Full Text] [Related]

  • 3. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O, Gilburd B, Chayat C, Lazar AD, Amital H, Blank M, Bentow C, Mahler M, Shoenfeld Y.
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [Abstract] [Full Text] [Related]

  • 4. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M, Mann H, Pleštilová L, Zámečník J, Betteridge Z, McHugh N, Vencovský J.
    Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
    [Abstract] [Full Text] [Related]

  • 5. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 6. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J.
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [Abstract] [Full Text] [Related]

  • 7. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.
    Llansó L, Segarra-Casas A, Domínguez-González C, Malfatti E, Kapetanovic S, Rodríguez-Santiago B, de la Calle O, Blanco R, Dobrescu A, Nascimento-Osorio A, Paipa A, Hernandez-Lain A, Jou C, Mariscal A, González-Mera L, Arteche A, Lleixà C, Caballero-Ávila M, Carbayo Á, Vesperinas A, Querol L, Gallardo E, Olivé M.
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428
    [Abstract] [Full Text] [Related]

  • 8. Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders.
    Woolley M, Stebbings S, Highton J.
    Intern Med J; 2018 Jan; 48(1):32-36. PubMed ID: 28782163
    [Abstract] [Full Text] [Related]

  • 9. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B, Horn MP, Banz Y, Feldmeyer L, Villiger PM.
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [Abstract] [Full Text] [Related]

  • 10. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.
    Kurashige T, Nakamura R, Murao T, Mine N, Sato M, Katsumata R, Kanaya Y, Dodo Y, Sugiura T, Ohshita T.
    BMC Immunol; 2024 May 11; 25(1):30. PubMed ID: 38734636
    [Abstract] [Full Text] [Related]

  • 11. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
    Ge Y, Lu X, Peng Q, Shu X, Wang G.
    PLoS One; 2015 May 11; 10(10):e0141616. PubMed ID: 26509687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E, Knight J, Khonasti S, Nolan D, McGettigan B, Bundell C, Needham M, Brusch A.
    Intern Med J; 2023 Oct 11; 53(10):1846-1853. PubMed ID: 36625419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 11; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.
    Yang H, Sun C, Ye L, Xu Y, Lin S, Peng Q, Wang G, Lu X.
    Arthritis Res Ther; 2024 Sep 11; 26(1):158. PubMed ID: 39261921
    [Abstract] [Full Text] [Related]

  • 20. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
    Hinschberger O, Lohmann C, Lannes B, Martzolff L, Vo BD, Jaeger-Bizet F, Ciobanu E, Kieffer P.
    Rev Med Interne; 2014 Aug 11; 35(8):546-9. PubMed ID: 23910221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.